A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis

Jin, LL; Sun, YX; Li, YY; Zhang, HY; Yu, WX; Li, YL; Xin, Y; Alsareii, SA; Wang, QY; Zhang, DB

Wang, QY (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China.; Zhang, DB (corresponding author), China Med Univ, Dept Stem Cells & Regenerat Med, Shenyang 110122, Peoples R China.

PEPTIDES, 2021; 143 ():

Abstract

Metabolic associated fatty liver disease (MAFLD) is the leading common chronic liver disease affecting more than one-quarter of the population worldwi......

Full Text Link